-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
Sign up for news updates
-
Tobacco Control Committee Chair Discusses Recent Legislative, Research Developments
In a Q&A with ILCN, Dr. William K. Evans weighs in on vaping and flavored tobacco regulations as well as cessation and prevention efforts.
-
Meeting News for Nov. 23, 2022
IASLC selects multidisciplinary slate of physicians to chair WCLC 2024 and announces last call for abstracts for TTLC 2023.
-
Regulatory News for Nov. 23, 2022
US Food and Drug Administration approves two combinations for non-small cell lung cancer.
-
Opinion: Updated Screening Guidance Needs More Commitment, Action Steps
Prof. Denis Horgan, executive director for the European Alliance for Personalised Medicine, writes that while the intentions behind the EU’s new cancer screening recommendations are laudable, they lack a roadmap for turning ideas into reality.
-
Alternative Approaches to Smoking Cessation May Fill Gap When Traditional Methods are Out of Reach
In Part 2 of our series on non-traditional methods to help patients quit smoking, Dr. Deepti Behl says it is important for healthcare providers to encourage their patients to quit smoking using current best practices as well as any other safe modality the patient perceives as helpful.
-
IASLC Releases Clinical Recommendations for Smoking Cessation After Cancer Diagnosis
While the harmful effects of smoking are well known, the negative impacts of continued smoking after a cancer diagnosis are underappreciated. With Lung Cancer Awareness Month under way, the association aims to change that with its new statement on tobacco cessation.
-
HER2 Mutations Present Unique Challenges in NSCLC
Drs. Stephanie Saw and Daniel Tan stress the importance of understanding the intricacies of HER2 testing in non-small cell lung cancer to optimize patient selection.
-
In Brief for Nov. 9, 2022
Go2 Foundation coordinates educational events across the United States to improve lung cancer awareness; abstract submissions open for 2023 European Lung Cancer Congress; and registration begins for inaugural Texas Lung Cancer Conference.
-
Growing Body of Evidence Highlights Potential Applications for Liquid Biopsy in Clinical Practice
During a lecture at NACLC 22, Dr. Christian Rolfo illustrated how ctDNA could be used to monitor progression and inform treatment decisions.
-
IASLC Leadership Shares Experiences, Offers Advice for Women in Thoracic Oncology
During a networking panel at NACLC 22, CEO Karen Kelly and President Heather Wakelee joined program co-chairs Drs. Jessica Donington, Marina Chiara Garassino, and Jyoti Patel for a discussion with other women in the field.
View ILCN Archives
Provider Resources
Popular Articles